nutrients-logo

Journal Browser

Journal Browser

Mechanisms of Adipokine Action in Obesity Mediated Metabolic Comorbidities

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Nutrition and Metabolism".

Deadline for manuscript submissions: closed (21 February 2022) | Viewed by 6351

Special Issue Editors


E-Mail Website
Guest Editor
Physiology and Pharmacology Department, Des Moines University, Des Moines, IA 50312, USA
Interests: sodium transport; renal diseases; acid-base balanced; adenosine receptor; dopamine receptor; Na+/H+ exchanger; calcium binding protein

E-Mail Website
Guest Editor
Biochemistry and Nutrition Department, Des Moines University, Des Moines, IA 50312, USA
Interests: hypertension; sympathetic activity; gender difference; leptin; central nervous system; post-menoopause

Special Issue Information

Dear Colleagues,

Obesity is a global health burden with associated high health care costs. It correlates with an excess of body fat accumulation that augments physiological changes and enhances the development of diseases such as type 2 diabetes mellitus, hypertension, cardiovascular and kidney diseases. Adipose tissue is in excess in obesity and is a source of hormonally active substances, i.e., the adipokines. Adipokines are a family of cytokines that have a complex set of actions that can be dysregulated in obesity.

The goal of this Special Issue on “Mechanisms of Adipokine Action in Obesity Mediated Metabolic Comorbidities” is to provide recent insights into the role of gender and/or age on release of adipokines and on the adipokines’ effect in the development, improvement and prevention of obesity-mediated metabolic diseases.

The data presented in each article will provide the scientific community with a compilation of recent findings on the impact of gender and/or age on the progression of metabolic diseases in obesity.

Prof. Dr. Francesca Di Sole
Prof. Dr. Maria J. Barnes
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • adipokines
  • hypertension
  • chronic kidney disease
  • neuro response
  • inflammation
  • type 2 diabetes mellitus
  • insulin resistance
  • age
  • gender difference
  • cardiovascular diseases

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

11 pages, 1577 KiB  
Article
Assessing the Causal Effects of Adipokines on Uric Acid and Gout: A Two-Sample Mendelian Randomization Study
by Ruyi Cong, Xiaoyu Zhang, Zihong Song, Shanshan Chen, Guanhua Liu, Yizhi Liu, Xiuyu Pang, Fang Dong, Weijia Xing, Youxin Wang and Xizhu Xu
Nutrients 2022, 14(5), 1091; https://0-doi-org.brum.beds.ac.uk/10.3390/nu14051091 - 05 Mar 2022
Cited by 4 | Viewed by 2707
Abstract
Previous observational studies have highlighted associations between adipokines and hyperuricemia, as well as gout, but the causality and direction of these associations are not clear. Therefore, we attempted to assess whether there are causal effects of specific adipokines (such as adiponectin (ADP) and [...] Read more.
Previous observational studies have highlighted associations between adipokines and hyperuricemia, as well as gout, but the causality and direction of these associations are not clear. Therefore, we attempted to assess whether there are causal effects of specific adipokines (such as adiponectin (ADP) and soluble leptin receptors (sOB-R)) on uric acid (UA) or gout in a two-sample Mendelian randomization (MR) analysis, based on summary statistics from large genome-wide association studies. The inverse-variance weighted (IVW) method was performed as the primary analysis. Sensitivity analyses (including MR-Egger regression, weighted median, penalized weighted median, and MR pleiotropy residual sum and outlier methods) were also performed, to ensure reliable results. In the IVW models, no causal effect was found for sOB-R (odds ratios (OR), 1.002; 95% confidence intervals (CI), 0.999–1.004; p = 0.274) on UA, or ADP (OR, 1.198; 95% CI, 0.865–1.659; p = 0.277) or sOB-R (OR, 0.988; 95% CI, 0.940–1.037; p = 0.616) on gout. The results were confirmed in sensitivity analyses. There was no notable directional pleiotropy or heterogeneity. This study suggests that these specific adipokines may not play causal roles in UA or gout development. Full article
Show Figures

Figure 1

Review

Jump to: Research

17 pages, 2207 KiB  
Review
Pro-Inflammatory Profile of Adipokines in Obesity Contributes to Pathogenesis, Nutritional Disorders, and Cardiovascular Risk in Chronic Kidney Disease
by Sylwia Czaja-Stolc, Marta Potrykus, Marta Stankiewicz, Łukasz Kaska and Sylwia Małgorzewicz
Nutrients 2022, 14(7), 1457; https://0-doi-org.brum.beds.ac.uk/10.3390/nu14071457 - 31 Mar 2022
Cited by 16 | Viewed by 3003
Abstract
Obesity is a disease which leads to the development of many other disorders. Excessive accumulation of lipids in adipose tissue (AT) leads to metabolic changes, including hypertrophy of adipocytes, macrophage migration, changes in the composition of immune cells, and impaired secretion of adipokines. [...] Read more.
Obesity is a disease which leads to the development of many other disorders. Excessive accumulation of lipids in adipose tissue (AT) leads to metabolic changes, including hypertrophy of adipocytes, macrophage migration, changes in the composition of immune cells, and impaired secretion of adipokines. Adipokines are cytokines produced by AT and greatly influence human health. Obesity and the pro-inflammatory profile of adipokines lead to the development of chronic kidney disease (CKD) through different mechanisms. In obesity and adipokine profile, there are gender differences that characterize the male gender as more susceptible to metabolic disorders accompanying obesity, including impaired renal function. The relationship between impaired adipokine secretion and renal disease is two-sided. In the developed CKD, the concentration of adipokines in the serum is additionally disturbed due to their insufficient excretion by the excretory system caused by renal pathology. Increased levels of adipokines affect the nutritional status and cardiovascular risk (CVR) of patients with CKD. This article aims to systematize the current knowledge on the influence of obesity, AT, and adipokine secretion disorders on the pathogenesis of CKD and their influence on nutritional status and CVR in patients with CKD. Full article
Show Figures

Figure 1

Back to TopTop